LatestNASA Selects Blue Origin to Manage Mars Mission Communications Network
Cannabis

New Mexico Credit Union to Close Cannabis Banking Arm

TG Branfalt
New Mexico Credit Union to Close Cannabis Banking Arm
Summary

The Albuquerque, New Mexico-based U.S. Eagle Federal Credit Union announced last week plans to close its cannabis banking arm, the Albuquerque Journal reports. The company said the closure of the Aery Group, which launched in 2019, is due to increased competition among financial services providers as the cannabis industry has grown. In an interview with the Journal, Michael Moore, president and CEO of U.S. […]

Originally published on

Ganjapreneur

By TG Branfalt

Read full article(opens in new tab)

Fetched: August 25, 2026 at 10:00 AM

Related News

More news you might be interested in

View all
BambashkART: Don't Bogart This Art
Cannabis

BambashkART: Don't Bogart This Art

A Bulgarian artist creates BambashkART as a visually stunning and spiritually uplifting artistic experience. This creative work celebrates the intersection of cannabis culture and fine art, offering viewers a feast for both the eyes and the soul. The piece represents the growing recognition of cannabis in artistic and cultural contexts, demonstrating how the plant inspires creative expression across different mediums. For individuals in Puerto Rico interested in cannabis culture and wellness, this artwork serves as a cultural bridge connecting art appreciation with the broader cannabis community.

22 hours ago
Cannabis Now
Rhode Island Reopens Cannabis Licensing Process for Adult-Use Sales
Cannabis

Rhode Island Reopens Cannabis Licensing Process for Adult-Use Sales

Rhode Island has reopened its application process for adult-use cannabis retail licenses following a constitutional dispute that invalidated the previous licensing round. The new licensing framework maintains dedicated opportunities for social equity applicants and worker cooperatives while eliminating the residency requirement that triggered the earlier legal challenge. This revised approach aims to support equitable market access while complying with constitutional standards. The reopened process represents an important step toward establishing a regulated cannabis market that balances social equity considerations with legal compliance.

yesterday
Revista Cáñamo
Thailo Rodríguez: Two Decades of Cannabis Cultivation, Activism, and Medical Regulation
Cannabis
Chronic Pain

Thailo Rodríguez: Two Decades of Cannabis Cultivation, Activism, and Medical Regulation

Thailo Rodríguez's journey began with a skateboarding injury that led him to explore cannabis as a therapeutic option, transforming his initial skepticism into two decades of advocacy and expertise. From personal cultivation and cannabis advocacy associations to regulated medical production, his evolution reflects Spain's broader shift in cannabis culture and acceptance of therapeutic applications. His work demonstrates how individual patient experiences drive policy change and medical legitimacy in cannabis access and regulation. For Puerto Rico's emerging medical cannabis framework, Rodríguez's experience illustrates the importance of bridging patient advocacy with evidence-based regulatory practices. His story underscores how personal medical necessity can catalyze professional expertise and systemic transformation in cannabis therapeutics.

yesterday
Revista Cáñamo
Medical Cannabis Private Prescriptions Surge 154% in England During 2025
Cannabis
AnxietyChronic Pain

Medical Cannabis Private Prescriptions Surge 154% in England During 2025

English pharmacies dispensed over 1.7 million medical cannabis products through private prescriptions in 2025, representing a 154% increase from the previous year. This surge reflects the rapid expansion of medical cannabis access following the United Kingdom's 2018 legalization reform, though the majority of growth continues outside the National Health Service system. The dramatic rise indicates growing physician acceptance and patient demand for cannabinoid therapies for various therapeutic indications. However, limited NHS coverage means access remains primarily available to patients with private insurance or personal resources, creating a two-tiered healthcare system for cannabis therapeutics.

yesterday
Revista Cáñamo